STOCK TITAN

UBS AG SEC Filings

AMUB NYSE

Welcome to our dedicated page for UBS SEC filings (Ticker: AMUB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on UBS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into UBS's regulatory disclosures and financial reporting.

Rhea-AI Summary

The issuer UBS AG is offering Trigger Callable Contingent Yield Notes linked to the least performing of the S&P 500®, Russell 2000® and Nasdaq-100® Technology Sector, with a total issue price of $1,176,000 and a per-Note issue price of $1,000. The Notes pay a contingent coupon of 10.10% per annum only when each underlying asset meets its coupon barrier on observation dates. UBS may call the Notes monthly beginning after three months; if not called, repayment at maturity depends on whether the final level of each underlying asset meets its downside threshold (65% of initial level). Estimated initial value per Note is $970.60. The Notes are unsecured obligations of UBS and repayment is subject to UBS credit risk.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG is offering $14,544,000 of Capped GEARS linked to the Russell 2000® Index. The Securities mature on June 30, 2027 (final valuation June 28, 2027) with a term of approximately 14 months. Each Security has an issue price of $10 and an estimated initial value of $9.785. At maturity a positive underlying return is multiplied by an upside gearing of 3.00 but the investor’s return is capped at a maximum gain of 21.55% (maximum payment $12.155 per Security). If the Russell 2000 final level is below the initial level, investors suffer the full downside of the index (possible loss of some or all principal). Payments are unsecured obligations of UBS and depend on UBS’ creditworthiness.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG offers a preliminary pricing supplement for Trigger Callable Contingent Yield Notes linked to the least performing of the S&P 500®, Russell 2000® and Nasdaq-100, due on or about June 1, 2029. The Notes pay a contingent coupon only if each underlying asset meets its coupon barrier on observation dates; otherwise no coupon is paid. The preliminary contingent coupon rate is 12.10% per annum. Issue price is $1,000.00 per Note with proceeds to UBS of $995.00 per Note after a $5.00 underwriting discount. Downside thresholds are 70.00% of initial levels and coupon barriers are 75.00% of initial levels. UBS may call the Notes quarterly beginning after six months; if not called and a final level of any underlying asset is below its downside threshold, principal repayment will be reduced proportionally to the loss of the least performing underlying asset. Payments are subject to UBS credit risk. The estimated initial value range is $959.40 to $989.40 as of the trade date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

The issuer, UBS AG, is offering Trigger Callable Contingent Yield Notes linked to the least performing of three ETFs: DIA (SPDR Dow Jones Industrial Average ETF), RSP (Invesco S&P 500 Equal Weight ETF) and XLV (Health Care Select Sector SPDR ETF). The Notes have a principal amount of $1,000 per Note, a contingent coupon rate of 8.10% per annum, monthly observation dates (callable after three months), an expected trade date of May 7, 2026, expected settlement May 12, 2026, final valuation date May 8, 2028 and maturity May 11, 2028. If UBS calls the Notes on an observation date, holders receive principal plus any contingent coupon then due. If not called, repayment at maturity equals principal only if each underlying’s final level is at or above its downside threshold (each set at 70.00% of its initial level); otherwise principal is reduced pro rata to the percentage decline of the least performing underlying asset, and in extreme cases investors may lose their entire investment. Estimated initial value on the trade date is expected between $951.60 and $981.60. Payments are subject to UBS credit risk.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS AG offers Trigger Autocallable Contingent Yield Notes linked to the least performing of the Nikkei 225® and the EURO STOXX 50®. The Notes have a principal amount of $10 per Note, trade date April 29, 2026, expected settlement April 30, 2026, final valuation date May 2, 2029 and expected maturity May 8, 2029.

The Notes pay periodic contingent coupons only if both underlying indices are at or above their coupon barriers on each observation date; the minimum contingent coupon rate disclosed is 9.65% per annum. The Notes are callable on specified quarterly observation dates (beginning after 12 months) if both indices are at or above call threshold levels (stated as 100.00% of initial levels), and principal repayment at maturity is contingent on the final levels relative to downside thresholds (stated as 65.00% of initial levels). The estimated initial value range is $9.431 to $9.731 per Note.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

UBS Group provides a detailed Pillar 3 update for 31 March 2026, highlighting strong capital and liquidity alongside rising regulatory demands. Common equity tier 1 (CET1) capital rose to USD 73.3bn, lifting the CET1 ratio to 14.65%, while risk‑weighted assets increased to USD 500.4bn.

Total loss‑absorbing capacity reached USD 197.6bn, supported by USD 3.7bn of new AT1 instruments and USD 9.0bn in TLAC‑eligible senior debt, partly offset by redemptions. UBS estimates future Swiss regulatory changes could require roughly USD 22bn of extra CET1 at UBS AG standalone and reduce Group CET1 by about USD 4bn, on top of around USD 15bn tied to the Credit Suisse acquisition.

Despite these headwinds, liquidity remains robust: the liquidity coverage ratio averaged 177.8% and the net stable funding ratio was 116.9%, both above FINMA requirements. UBS also returned capital, with shareholders approving a USD 1.10 per share dividend and the Group repurchasing USD 0.9bn of shares in the quarter as part of a planned USD 3bn buyback by July 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

UBS Group delivered a strong first quarter of 2026, with total revenues of $14.243bn, up 13% year on year, and net profit attributable to shareholders of $3.040bn, up 80%. Diluted earnings per share rose to $0.94, and the reported cost / income ratio improved to 72.5%.

Profit growth was broad-based: Global Wealth Management, Personal & Corporate Banking, Asset Management and the Investment Bank all increased pre-tax profit, helped by higher fee income, stronger markets and higher client activity. Underlying pre-tax profit reached $3.99bn, with an underlying cost / income ratio of 70.2%.

Integration of Credit Suisse is advancing, with cumulative gross cost savings of $11.5bn toward a $13.5bn 2026 ambition. UBS highlights upcoming Swiss regulatory changes that could require about $37bn of additional CET1 capital over time, but the Group CET1 ratio is currently a solid 14.7%. UBS also paid a $1.10 dividend per share and repurchased $0.9bn of shares in the quarter.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

UBS AG London Branch is offering Contingent Income Auto-Callable Securities linked to the Class A common stock of Alphabet Inc. (GOOGL). Each security has a stated principal amount of $1,000, an expected pricing date of April 29, 2026, an expected original issue date of May 4, 2026 and an expected maturity of November 3, 2026.

Holders may receive a $11.50 contingent payment per security on a determination date if the closing price of GOOGL is ≥ the downside threshold (80.00% of the initial price). The securities may be auto-redeemed early if the closing price on an applicable determination date (starting with the third determination date) is ≥ the call threshold (100.00% of the initial price). If not redeemed and the final price is below the downside threshold, UBS has elected to deliver cash in lieu of shares and investors will receive a cash value equal to the exchange ratio × final price, exposing holders to a potential loss of a significant portion or all of principal. The estimated initial value range at pricing is $948.90–$978.90.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to Intel Corporation stock due May 1, 2028. The Notes pay periodic contingent coupons only if the underlying closing level on observation dates meets or exceeds a coupon barrier and will be automatically called early if the underlying closing level on any observation date prior to the final valuation date is equal to or greater than the initial level. If not called and the final level is below the downside threshold, principal repayment is reduced pro rata to the underlying return, and investors could lose a significant portion or all of their initial investment. Payments depend on UBS creditworthiness. Trade and settlement dates are April 28, 2026 and April 30, 2026, with final valuation date April 27, 2028 and maturity May 1, 2028. The offering size shown is $835,000 and the minimum investment is 100 Notes at $10 per Note.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus

FAQ

How many UBS (AMUB) SEC filings are available on StockTitan?

StockTitan tracks 8006 SEC filings for UBS (AMUB), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for UBS (AMUB)?

The most recent SEC filing for UBS (AMUB) was filed on April 29, 2026.